Not applicableStudy completedNCT03590938What this trial is testingLynparza Breast Cancer Clinical Experience InvestigationWho this might be right forBreast Cancer AstraZeneca 111
Testing effectiveness (Phase 2)Study completedNCT00777049What this trial is testingStudy of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast CancerWho this might be right forBreast Cancer Translational Research in Oncology 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07164976What this trial is testingRibociclib for HR-positive HER2-negative Metastatic Breast CancerWho this might be right forBreast Cancer Nagoya City University 86
Not applicableActive Not RecruitingNCT05677308What this trial is testingLYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)Who this might be right forBreast Cancer AstraZeneca 61
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037What this trial is testingTamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerWho this might be right forBreast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more National Cancer Institute (NCI) 5,018
Large-scale testing (Phase 3)Study completedNCT01131195What this trial is testingMetronomic Therapy in Metastatic Breast Cancer.Who this might be right forBreast Cancer Swiss Cancer Institute 139
Early research (Phase 1)Active Not RecruitingNCT03725436What this trial is testingALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT05912933What this trial is testingLearn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)Who this might be right forBreast Cancer Pfizer 733
Large-scale testing (Phase 3)Active Not RecruitingNCT03315364What this trial is testingOral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyWho this might be right forRecurrent or Metastatic Breast Cancer Daehwa Pharmaceutical Co., Ltd. 549
Testing effectiveness (Phase 2)Ended earlyNCT02892734What this trial is testingIpilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast CancerWho this might be right forHER2/Neu NegativeRecurrent Inflammatory Breast CarcinomaStage IV Breast Cancer+1 more Northwestern University 3
Large-scale testing (Phase 3)Study completedNCT00785291What this trial is testingPaclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+6 more National Cancer Institute (NCI) 799
Large-scale testing (Phase 3)UnknownNCT00532727What this trial is testingTriple Negative Breast Cancer TrialWho this might be right forBreast Cancer Institute of Cancer Research, United Kingdom 400
Testing effectiveness (Phase 2)Study completedNCT00217672What this trial is testingDocetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast CancerWho this might be right forBreast Cancer Translational Oncology Research International 76
Large-scale testing (Phase 3)Looking for participantsNCT07190443What this trial is testingAdjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)Who this might be right forBreast CancerLocoregional RecurrenceAbemaciclib+1 more Japanese Foundation for Cancer Research 290
Large-scale testing (Phase 3)Active Not RecruitingNCT03820830What this trial is testingPalbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast CancerWho this might be right forBreast Cancer Recurrent ETOP IBCSG Partners Foundation 405
Testing effectiveness (Phase 2)UnknownNCT05263882What this trial is testingGemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast CancerWho this might be right forHER2-negative Breast Cancer Fifth Affiliated Hospital, Sun Yat-Sen University 58
Not applicableStudy completedNCT03154190What this trial is testingHealth Care Coach Support in Reducing Acute Care Use and Cost in Patients With CancerWho this might be right forAcute Myeloid LeukemiaBrain GlioblastomaEstrogen Receptor Negative+64 more Stanford University 128
Early research (Phase 1)Study completedNCT02672475What this trial is testingGalunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+3 more Vanderbilt-Ingram Cancer Center 29
Large-scale testing (Phase 3)Ended earlyNCT03786094What this trial is testingPivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast CancerWho this might be right forMetastatic Breast CancerLocally Recurrent Breast Cancer Spexis AG 432
Large-scale testing (Phase 3)Active Not RecruitingNCT02115282What this trial is testingExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Breast Adenocarcinoma+4 more National Cancer Institute (NCI) 608